FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I or a physiologically acceptable salt thereof, where X denotes (C1-C6)alkanediiyloxy group, where oxygen atom of (C1-C6)alkanediiyloxy group is bonded with a group Y; Y denotes phenylene, where in phenylene one or more carbon atoms contained in ring are optionally substituted with identical or different substitutes R5; R1 denotes a hydrogen atom; R2 and R3 are independently selected from H and halogen; R5 denotes (C1-C4)alkyl. Invention also relates to a pharmaceutical composition for activation of EDG-1 receptor, containing at least one compound of formula I or its physiologically acceptable salt and pharmaceutically acceptable carrier.
EFFECT: technical result is derivatives of carboxylic acids with oxazole[5,4-b]pyridine cycle for use as a medicinal agent for EDG-1 receptor activation.
4 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[5,4-d]PYRIMIDINE CYCLE | 2012 |
|
RU2609008C2 |
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5,7-SUBSTITUTED OXAZOLE PYRIMIDINE RING | 2011 |
|
RU2560876C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS WITH OXAZOLE[4,5-c]PYRIDINE CYCLE | 2012 |
|
RU2609004C2 |
| CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2564018C2 |
| HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2559896C2 |
| CARBOXYLIC ACID DERIVATIVES, HAVING OXAZOLE[4,5-D]PYRIMIDINE RING | 2012 |
|
RU2609003C2 |
| 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES | 2011 |
|
RU2554874C2 |
| DERIVATIVE OF HETEROCYCLIC CARBON ACIDS, WHICH CONTAIN 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2554869C2 |
| HETEROARYL-SUBSTITUTED AMIDES CONTAINING SATURATED BINDING GROUP AND USE THEREOF AS PHARMACEUTICAL AGENTS | 2006 |
|
RU2412181C2 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
